{"id":"W2145378676","doi":"10.1093/annonc/mdn292","title":"Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies","year":2008,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Dalhousie University","funders":"","keywords":"Trastuzumab; Cardiotoxicity; Medicine; Anthracycline; Doxorubicin; Breast cancer; Oncology; Internal medicine; Adjuvant; Pharmacology; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003096584,0.0005338207,0.002955494,0.0002836178,0.0001593824,0.00003214107,0.0003494948,0.0006254889,0.0001821716],"category_scores_gemma":[0.00008410895,0.0004226257,0.0004657283,0.0003289772,0.0008528144,0.0001676116,0.0001569961,0.0008877693,0.000004707673],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002655977,"about_ca_system_score_gemma":0.005225187,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002021551,"about_ca_topic_score_gemma":0.00003240552,"domain_scores_codex":[0.9967417,0.00023311,0.001004642,0.0007863184,0.0004669602,0.0007673426],"domain_scores_gemma":[0.9973683,0.0004310623,0.0007244388,0.000579071,0.0005742107,0.0003228598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001511995,0.0003057893,0.00002483258,0.01835998,0.0001841443,0.00006762543,0.0005721363,3.641098e-7,0.00001012203,0.0001479155,0.029767,0.9504089],"study_design_scores_gemma":[0.0007440863,0.001140653,0.0001313575,0.01251035,0.0002129447,0.001200414,0.0004543597,0.000006295968,0.00001907333,0.00004647782,0.9832161,0.0003178797],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002604618,0.9927558,0.00001962419,0.002452982,0.0008531776,0.001685058,0.0007344216,0.0000389501,0.001199533],"genre_scores_gemma":[0.0002004802,0.9955008,0.0003457162,0.0001698371,0.002692487,0.0007764129,0.0001049674,0.00008731776,0.0001219594],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9534491,"threshold_uncertainty_score":0.9998226,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2965734513227626,"score_gpt":0.5799490487503968,"score_spread":0.2833755974276342,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}